AnalystsSTEPHEN UNGERSTEPHEN UNGER's Stock Forecasts
AnalystsSTEPHEN UNGER
Analyst Ranking
Top 7%
#300 out of 4873 analysts
Average Return
+64.48%
Win Rate
96%22 out of 23
Risk vs Reward
Poor
Good
STEPHEN UNGER's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oncocyte CorpOCX | +244.05% | $33.60 | $115.60 | 2020-06-30 - 2021-07-01 | Buy |
Cryoport IncCYRX | +188.30% | $18.21 | $52.50 | 2020-03-05 - 2021-03-05 | Buy |
Veracyte IncVCYT | +149.61% | $23.26 | $58.06 | 2020-02-25 - 2021-02-26 | Buy |
Neogenomics IncNEO | +113.06% | $24.05 | $51.24 | 2020-03-16 - 2021-03-17 | Buy |
Oncocyte CorpOCX | +79.31% | $34.80 | $62.40 | 2020-11-12 - 2021-11-12 | Buy |
STEPHEN UNGER Analyst Color
Get additional color on STEPHEN UNGER's coverage of popular stocks
STEPHEN UNGER's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Thermo Fisher Scientific IncTMO | 7 | Buy | $539.00 | N/A | Maintains | 4 years ago |
Oncocyte CorpOCX | 3 | Buy | $80.00 | N/A | Maintains | 4 years ago |
Revvity IncRVTY | 2 | Buy | $193.00 | N/A | Maintains | 5 years ago |
Cryoport IncCYRX | 3 | Buy | $45.00 | N/A | Maintains | 5 years ago |
Neogenomics IncNEO | 3 | Buy | $46.00 | N/A | Maintains | 5 years ago |
Personalis IncPSNL | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Azenta IncAZTA | 2 | Buy | $72.00 | N/A | Upgrades | 5 years ago |
Veracyte IncVCYT | 2 | Buy | $37.00 | N/A | Maintains | 5 years ago |
Danaher CorpDHR | 1 | Buy | $209.00 | N/A | Maintains | 5 years ago |
Bruker CorpBRKR | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Agilent Technologies IncA | 1 | Hold | $85.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.